Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 6 | 2025 | 24 | 3.090 |
Why?
|
| HIV Infections | 8 | 2024 | 115 | 2.720 |
Why?
|
| Bronchiectasis | 5 | 2021 | 5 | 1.300 |
Why?
|
| Humans | 42 | 2025 | 5476 | 1.060 |
Why?
|
| Military Personnel | 1 | 2025 | 23 | 0.910 |
Why?
|
| Self-Injurious Behavior | 1 | 2024 | 8 | 0.890 |
Why?
|
| United States | 16 | 2025 | 521 | 0.850 |
Why?
|
| Smoking Prevention | 7 | 2022 | 15 | 0.830 |
Why?
|
| Microbiota | 2 | 2021 | 18 | 0.790 |
Why?
|
| Quadriceps Muscle | 1 | 2022 | 1 | 0.780 |
Why?
|
| Female | 25 | 2025 | 2811 | 0.700 |
Why?
|
| Male | 24 | 2025 | 2765 | 0.670 |
Why?
|
| Risk Factors | 5 | 2024 | 184 | 0.660 |
Why?
|
| Cohort Studies | 8 | 2023 | 131 | 0.500 |
Why?
|
| Aged | 12 | 2024 | 859 | 0.490 |
Why?
|
| Neoplasms | 2 | 2014 | 99 | 0.480 |
Why?
|
| Physician Assistants | 2 | 2014 | 2 | 0.470 |
Why?
|
| Early Detection of Cancer | 2 | 2014 | 9 | 0.460 |
Why?
|
| Case-Control Studies | 3 | 2024 | 96 | 0.460 |
Why?
|
| Advanced Practice Nursing | 1 | 2014 | 1 | 0.440 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 53 | 0.420 |
Why?
|
| Adolescent | 14 | 2022 | 806 | 0.400 |
Why?
|
| Accidental Falls | 3 | 2022 | 16 | 0.400 |
Why?
|
| Smoking | 5 | 2022 | 94 | 0.390 |
Why?
|
| Middle Aged | 9 | 2024 | 1098 | 0.380 |
Why?
|
| Polypharmacy | 3 | 2022 | 11 | 0.380 |
Why?
|
| Tobacco, Smokeless | 2 | 2022 | 2 | 0.380 |
Why?
|
| Tobacco Products | 3 | 2022 | 39 | 0.370 |
Why?
|
| Substance-Related Disorders | 3 | 2023 | 52 | 0.360 |
Why?
|
| Adult | 8 | 2024 | 1683 | 0.360 |
Why?
|
| Vaping | 2 | 2022 | 11 | 0.350 |
Why?
|
| Health Promotion | 3 | 2020 | 39 | 0.340 |
Why?
|
| Electronic Nicotine Delivery Systems | 2 | 2022 | 20 | 0.340 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 148 | 0.320 |
Why?
|
| Lung | 2 | 2019 | 42 | 0.310 |
Why?
|
| Guideline Adherence | 3 | 2018 | 6 | 0.280 |
Why?
|
| United Kingdom | 2 | 2025 | 9 | 0.270 |
Why?
|
| Tobacco Use | 3 | 2022 | 22 | 0.270 |
Why?
|
| Child | 9 | 2022 | 657 | 0.260 |
Why?
|
| Sputum | 3 | 2021 | 3 | 0.260 |
Why?
|
| Smoking Cessation | 2 | 2019 | 137 | 0.250 |
Why?
|
| Australia | 1 | 2025 | 1 | 0.230 |
Why?
|
| Food Supply | 2 | 2014 | 11 | 0.230 |
Why?
|
| Nutritional Status | 2 | 2022 | 7 | 0.230 |
Why?
|
| Vaccines | 2 | 2014 | 5 | 0.220 |
Why?
|
| Cause of Death | 1 | 2024 | 2 | 0.220 |
Why?
|
| Suicide | 1 | 2024 | 11 | 0.220 |
Why?
|
| Mitragyna | 1 | 2023 | 2 | 0.220 |
Why?
|
| Social Media | 1 | 2023 | 8 | 0.210 |
Why?
|
| Spinal Cord Diseases | 1 | 2023 | 1 | 0.210 |
Why?
|
| Demyelinating Diseases | 1 | 2023 | 3 | 0.200 |
Why?
|
| Program Evaluation | 3 | 2020 | 28 | 0.200 |
Why?
|
| Malnutrition | 1 | 2022 | 1 | 0.200 |
Why?
|
| Acetabulum | 1 | 2022 | 1 | 0.200 |
Why?
|
| Surgical Flaps | 1 | 2022 | 2 | 0.200 |
Why?
|
| Hip Joint | 1 | 2022 | 4 | 0.200 |
Why?
|
| Comorbidity | 2 | 2020 | 49 | 0.190 |
Why?
|
| Prostatic Hyperplasia | 2 | 2012 | 3 | 0.190 |
Why?
|
| Meta-Analysis as Topic | 1 | 2022 | 4 | 0.190 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2021 | 3 | 0.190 |
Why?
|
| Fractures, Bone | 1 | 2021 | 8 | 0.190 |
Why?
|
| RNA | 1 | 2022 | 30 | 0.180 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 36 | 0.180 |
Why?
|
| Maternal Health | 1 | 2020 | 1 | 0.170 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 107 | 0.160 |
Why?
|
| Awareness | 1 | 2020 | 6 | 0.160 |
Why?
|
| Schools | 2 | 2021 | 39 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2020 | 11 | 0.160 |
Why?
|
| Pregnancy Proteins | 1 | 2019 | 2 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 5 | 0.160 |
Why?
|
| Extracellular Traps | 1 | 2019 | 3 | 0.160 |
Why?
|
| School Health Services | 2 | 2020 | 7 | 0.160 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 277 | 0.160 |
Why?
|
| Mass Media | 1 | 2019 | 2 | 0.160 |
Why?
|
| Tobacco Smoking | 1 | 2019 | 13 | 0.160 |
Why?
|
| Menthol | 1 | 2019 | 1 | 0.160 |
Why?
|
| Disease Progression | 4 | 2021 | 74 | 0.160 |
Why?
|
| Leukocyte Elastase | 1 | 2019 | 1 | 0.160 |
Why?
|
| Behavior, Addictive | 1 | 2019 | 10 | 0.160 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2019 | 7 | 0.160 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 19 | 0.160 |
Why?
|
| Point-of-Care Testing | 1 | 2019 | 10 | 0.160 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 40 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2020 | 52 | 0.150 |
Why?
|
| Pulmonary Medicine | 1 | 2018 | 1 | 0.150 |
Why?
|
| Bacteria | 1 | 2019 | 52 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 14 | 0.150 |
Why?
|
| Young Adult | 6 | 2020 | 850 | 0.150 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 9 | 0.150 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 20 | 0.150 |
Why?
|
| Algorithms | 1 | 2020 | 276 | 0.140 |
Why?
|
| Immunization | 2 | 2014 | 2 | 0.140 |
Why?
|
| Sampling Studies | 1 | 2017 | 3 | 0.140 |
Why?
|
| Patient Selection | 1 | 2017 | 10 | 0.140 |
Why?
|
| Internet | 1 | 2017 | 35 | 0.130 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 71 | 0.120 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 22 | 0.120 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 1 | 0.110 |
Why?
|
| Food Assistance | 1 | 2014 | 2 | 0.110 |
Why?
|
| Weight Gain | 1 | 2014 | 28 | 0.110 |
Why?
|
| Body Weight | 1 | 2014 | 59 | 0.110 |
Why?
|
| Physicians, Primary Care | 1 | 2014 | 8 | 0.110 |
Why?
|
| Professional Role | 1 | 2014 | 4 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 22 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2021 | 132 | 0.110 |
Why?
|
| Urinalysis | 1 | 2013 | 1 | 0.110 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2013 | 3 | 0.110 |
Why?
|
| Urine | 1 | 2013 | 5 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 6 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2014 | 70 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 320 | 0.100 |
Why?
|
| Pregnancy | 3 | 2020 | 103 | 0.100 |
Why?
|
| Urology | 1 | 2012 | 1 | 0.100 |
Why?
|
| Kidney Calculi | 1 | 2012 | 6 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2012 | 6 | 0.100 |
Why?
|
| Health Expenditures | 1 | 2012 | 19 | 0.090 |
Why?
|
| Medicare | 1 | 2012 | 79 | 0.090 |
Why?
|
| Self Report | 3 | 2019 | 72 | 0.090 |
Why?
|
| Religion and Sex | 1 | 2010 | 1 | 0.090 |
Why?
|
| Religion and Psychology | 1 | 2010 | 4 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 183 | 0.090 |
Why?
|
| Animals | 3 | 2023 | 1817 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 2010 | 29 | 0.090 |
Why?
|
| Health Behavior | 1 | 2010 | 38 | 0.090 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2020 | 7 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 350 | 0.080 |
Why?
|
| Quality of Life | 2 | 2021 | 117 | 0.080 |
Why?
|
| Biomarkers | 2 | 2019 | 87 | 0.080 |
Why?
|
| Prevalence | 2 | 2021 | 72 | 0.070 |
Why?
|
| Health Education | 2 | 2020 | 20 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2020 | 100 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 43 | 0.070 |
Why?
|
| Linear Models | 2 | 2019 | 60 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 75 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2017 | 19 | 0.060 |
Why?
|
| Honduras | 2 | 2014 | 2 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 1 | 2023 | 9 | 0.050 |
Why?
|
| Autopsy | 1 | 2023 | 1 | 0.050 |
Why?
|
| Cervical Vertebrae | 1 | 2023 | 1 | 0.050 |
Why?
|
| Cadaver | 1 | 2023 | 3 | 0.050 |
Why?
|
| Motivation | 1 | 2023 | 70 | 0.050 |
Why?
|
| Nutrition Assessment | 1 | 2022 | 3 | 0.050 |
Why?
|
| Frail Elderly | 1 | 2022 | 3 | 0.050 |
Why?
|
| Geriatric Assessment | 1 | 2022 | 7 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 35 | 0.050 |
Why?
|
| Radiobiology | 1 | 2022 | 1 | 0.050 |
Why?
|
| Circadian Clocks | 1 | 2022 | 5 | 0.050 |
Why?
|
| Osteoporotic Fractures | 1 | 2021 | 2 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2021 | 4 | 0.050 |
Why?
|
| Aging | 1 | 2022 | 127 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 49 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 81 | 0.040 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2020 | 2 | 0.040 |
Why?
|
| Afghan Campaign 2001- | 1 | 2020 | 2 | 0.040 |
Why?
|
| Students | 1 | 2021 | 122 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 19 | 0.040 |
Why?
|
| Flavoring Agents | 1 | 2019 | 1 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 6 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2019 | 13 | 0.040 |
Why?
|
| Health Status | 1 | 2020 | 30 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 26 | 0.040 |
Why?
|
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2019 | 1 | 0.040 |
Why?
|
| Europe | 1 | 2019 | 3 | 0.040 |
Why?
|
| Lactoferrin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Cathelicidins | 1 | 2019 | 6 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 1 | 0.040 |
Why?
|
| Spain | 1 | 2019 | 1 | 0.040 |
Why?
|
| Logistic Models | 1 | 2019 | 69 | 0.040 |
Why?
|
| Neutrophils | 1 | 2019 | 19 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 97 | 0.040 |
Why?
|
| Muramidase | 1 | 2019 | 33 | 0.040 |
Why?
|
| Editorial Policies | 1 | 2018 | 1 | 0.040 |
Why?
|
| Journal Impact Factor | 1 | 2018 | 2 | 0.040 |
Why?
|
| Phenotype | 1 | 2019 | 73 | 0.040 |
Why?
|
| Smokers | 1 | 2019 | 49 | 0.040 |
Why?
|
| Cost Savings | 1 | 2018 | 3 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2018 | 8 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 74 | 0.040 |
Why?
|
| Public Health | 1 | 2018 | 22 | 0.040 |
Why?
|
| Mice | 1 | 2019 | 719 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2014 | 1 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 9 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 5 | 0.030 |
Why?
|
| Viral Load | 1 | 2014 | 2 | 0.030 |
Why?
|
| Counseling | 1 | 2014 | 15 | 0.030 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 2014 | 1 | 0.030 |
Why?
|
| Chickenpox Vaccine | 1 | 2014 | 1 | 0.030 |
Why?
|
| Rotavirus Vaccines | 1 | 2014 | 1 | 0.030 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2014 | 1 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2014 | 3 | 0.030 |
Why?
|
| Patient Safety | 1 | 2014 | 10 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 2 | 0.030 |
Why?
|
| Nurses | 1 | 2014 | 3 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2014 | 119 | 0.030 |
Why?
|
| Mass Screening | 1 | 2014 | 11 | 0.030 |
Why?
|
| Curriculum | 1 | 2014 | 50 | 0.030 |
Why?
|
| California | 1 | 2013 | 10 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2013 | 10 | 0.030 |
Why?
|
| Recurrence | 1 | 2013 | 26 | 0.030 |
Why?
|
| Infant | 1 | 2013 | 87 | 0.030 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2012 | 1 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 187 | 0.020 |
Why?
|
| Inflation, Economic | 1 | 2012 | 1 | 0.020 |
Why?
|
| Laser Coagulation | 1 | 2012 | 1 | 0.020 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2012 | 1 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 16 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 9 | 0.020 |
Why?
|
| Prostate | 1 | 2012 | 10 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 21 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 33 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 53 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 382 | 0.020 |
Why?
|
| Reproductive Health Services | 1 | 2010 | 1 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 35 | 0.020 |
Why?
|
| Obesity | 1 | 2012 | 118 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 284 | 0.020 |
Why?
|